bioAffinity Technologies, Inc. (BIAFW) Capital expenditures 2022–2025
bioAffinity Technologies, Inc. (BIAFW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$60,568FY2025 · since FY2022: $219,987 → $60,568
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $60,568 | -23.4% |
| FY2024 | $79,083 | +245.3% |
| FY2023 | $22,902 | -89.6% |
| FY2022 | $219,987 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAFW financial trends
BIAFW RevenueBIAFW Net incomeBIAFW Net marginBIAFW Gross profitBIAFW Gross marginBIAFW Operating incomeBIAFW Operating marginBIAFW Operating cash flowBIAFW Free cash flowBIAFW Return on equityBIAFW Stock buybacksBIAFW Dividends paidBIAFW Total assetsBIAFW Total liabilitiesBIAFW Shareholders’ equityBIAFW overview →